Idarubicin Injection 10 mg/10 mL (4)

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

idarubicin hydrochloride, Quantity: 1 mg/mL

Disponible desde:

Pfizer (Perth) Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Vía de administración:

Intravenous, Intravenous Infusion

Unidades en paquete:

1 x 10 mL

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Zavedos is used to treat acute myeloid and lymphoid leukaemia (types of blood cancer) in adults and children. Zavedos may be administered as a monotherapy or as part of combination therapy (with cytarabine).

Resumen del producto:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Listed (Export Only)

Fecha de autorización:

2023-03-03